In this Issue:
Perioperative romiplostim in chronic ITP
Prolonged sirolimus decreases GVHD risk post-transplant
AML without induction chemotherapy
Front-line ABVD outcomes in elderly Hodgkin’s lymphoma
Bendamustine/thalidomide/ dexamethasone in relapsed/ refractory MM
Oral clofarabine + low-dose cytarabine in AML and MDS
Long-term outcomes with high-dose imatinib in paediatric chronic-phase CML
INPP4B overexpression in AML
Dinaciclib in relapsed/refractory CLL
Please login below to download this issue (PDF)